» Articles » PMID: 15226449

Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Jul 1
PMID 15226449
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The antiapoptotic function of the interleukin-7 (IL-7) receptor is related to regulation of three members of the Bcl2 family: synthesis of Bcl2, phosphorylation of Bad, and cytosolic retention of Bax. Here we show that, in an IL-7-dependent murine T-cell line, different regions of the IL-7 receptor initiate the signal transduction pathways that regulate these proteins. Both Box1 and Y449 are required to signal Bcl2 synthesis and Bax cytosolic retention. This suggests a sequential model in which Jak1, which binds to Box1, is first activated and then phosphorylates Y449, leading to Bcl2 and Bax regulation, accounting for approximately 90% of the survival function. Phosphorylation of Bad required Box1 but not Y449, suggesting that Jak1 also initiates an additional signaling cascade that accounts for approximately 10% of the survival function. Stat5 was activated from the Y449 site but only partially accounted for the survival signal. Proliferation required both Y449 and Box1. Thymocyte development in vivo showed that deletion of Y449 eliminated 90% of alphabeta T-cell development and completely eliminated gammadelta T-cell development, whereas deleting Box 1 completely eliminated both alphabeta and gammadelta T-cell development. Thus the IL-7 receptor controls at least two distinct pathways, in addition to Stat5, that are required for cell survival.

Citing Articles

Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.

Sakunrangsit N, Khuisangeam N, Inthanachai T, Yodsurang V, Taechawattananant P, Suppipat K Cancer Immunol Immunother. 2024; 73(6):98.

PMID: 38619641 PMC: 11018726. DOI: 10.1007/s00262-024-03685-7.


Concepts in B cell acute lymphoblastic leukemia pathogenesis.

Garcia C, Miller-Awe M, Witkowski M J Leukoc Biol. 2024; 116(1):18-32.

PMID: 38243586 PMC: 11869204. DOI: 10.1093/jleuko/qiae015.


DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies.

Giardino Torchia M, Moody G Front Immunol. 2023; 14:1264882.

PMID: 38090585 PMC: 10713823. DOI: 10.3389/fimmu.2023.1264882.


IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion.

Kaiser F, Janowska I, Menafra R, de Gier M, Korzhenevich J, Pico-Knijnenburg I Blood. 2023; 142(13):1113-1130.

PMID: 37369082 PMC: 10644098. DOI: 10.1182/blood.2023019721.


Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias.

Angot L, Schneider P, Vannier J, Abdoul-Azize S Cancers (Basel). 2023; 15(10).

PMID: 37345151 PMC: 10216755. DOI: 10.3390/cancers15102812.


References
1.
Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H . Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci U S A. 1996; 93(14):7172-7. PMC: 38955. DOI: 10.1073/pnas.93.14.7172. View

2.
Grabstein K, Waldschmidt T, Finkelman F, Hess B, Alpert A, Boiani N . Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med. 1993; 178(1):257-64. PMC: 2191094. DOI: 10.1084/jem.178.1.257. View

3.
Dadi H, Ke S, Roifman C . Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. Blood. 1994; 84(5):1579-86. View

4.
Datta S, Dudek H, Tao X, Masters S, Fu H, Gotoh Y . Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997; 91(2):231-41. DOI: 10.1016/s0092-8674(00)80405-5. View

5.
Macchi P, Villa A, Giliani S, Sacco M, Frattini A, Porta F . Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 1995; 377(6544):65-8. DOI: 10.1038/377065a0. View